Original Research
Published on 22 Mar 2024
Cost-effectiveness analysis of amivantamab plus chemotherapy versus chemotherapy alone in NSCLC with EGFR Exon 20 insertions
in Cancer Genetics
- 6,623 views
- 8 citations
Original Research
Published on 22 Mar 2024
in Cancer Genetics
Editorial
Published on 21 Mar 2024
in Cancer Genetics
Case Report
Published on 14 Mar 2024
in Cancer Genetics
Original Research
Published on 14 Mar 2024
in Cancer Genetics
Correction
Published on 13 Mar 2024
in Cancer Genetics
Systematic Review
Published on 12 Mar 2024
in Cancer Genetics
Review
Published on 08 Mar 2024
in Cancer Genetics
Original Research
Published on 21 Feb 2024
in Cancer Genetics
Review
Published on 21 Feb 2024
in Cancer Genetics
Original Research
Published on 06 Feb 2024
in Cancer Genetics
Case Report
Published on 31 Jan 2024
in Cancer Genetics
Original Research
Published on 24 Jan 2024
in Cancer Genetics
Case Report
Published on 23 Jan 2024
in Cancer Genetics
Original Research
Published on 19 Jan 2024
in Cancer Genetics
Original Research
Published on 18 Jan 2024
in Cancer Genetics
Case Report
Published on 08 Jan 2024
in Cancer Genetics
Original Research
Published on 08 Jan 2024
in Cancer Genetics
Editorial
Published on 08 Jan 2024
in Cancer Genetics
Mini Review
Published on 21 Dec 2023
in Cancer Genetics
Systematic Review
Published on 07 Dec 2023
in Cancer Genetics
Original Research
Published on 30 Nov 2023
in Cancer Genetics
Retraction
Published on 27 Nov 2023
in Cancer Genetics
Original Research
Published on 07 Nov 2023
in Cancer Genetics
Original Research
Published on 31 Oct 2023
in Cancer Genetics